Charles Schwab’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $57.3M | Buy |
557,131
+20,020
| +4% | +$1.3M | 0.01% | 1157 |
|
|
2026
Q1 | $25.5M | Sell |
537,111
-11,281
| -2% | -$506K | ﹤0.01% | 1597 |
|
|
2025
Q4 | $17.4M | Sell |
548,392
-25,240
| -4% | -$787K | ﹤0.01% | 1839 |
|
|
2025
Q3 | $16.1M | Sell |
573,632
-20,449
| -3% | -$619K | ﹤0.01% | 1864 |
|
|
2025
Q2 | $21.9M | Buy |
594,081
+81,666
| +16% | +$2.82M | ﹤0.01% | 1622 |
|
|
2025
Q1 | $20.1M | Sell |
512,415
-30,417
| -6% | -$1.37M | ﹤0.01% | 1639 |
|
|
2024
Q4 | $25.2M | Buy |
542,832
+17,890
| +3% | +$808K | ﹤0.01% | 1572 |
|
|
2024
Q3 | $23.7M | Buy |
524,942
+24,582
| +5% | +$1.17M | ﹤0.01% | 1604 |
|
|
2024
Q2 | $24.7M | Buy |
500,360
+42,425
| +9% | +$1.73M | ﹤0.01% | 1537 |
|
|
2024
Q1 | $15.7M | Buy |
457,935
+9,703
| +2% | +$350K | ﹤0.01% | 1748 |
|
|
2023
Q4 | $16.5M | Buy |
448,232
+5,728
| +1% | +$132K | ﹤0.01% | 1703 |
|
|
2023
Q3 | $8.97M | Buy |
442,504
+14,511
| +3% | +$319K | ﹤0.01% | 1970 |
|
|
2023
Q2 | $8.76M | Buy |
427,993
+5,064
| +1% | +$75.9K | ﹤0.01% | 1967 |
|
|
2023
Q1 | $6.38M | Buy |
422,929
+3,867
| +0.9% | +$85.4K | ﹤0.01% | 2094 |
|
|
2022
Q4 | $9.98M | Buy |
419,062
+9,023
| +2% | +$262K | ﹤0.01% | 1858 |
|
|
2022
Q3 | $14.4M | Sell |
410,039
-10,941
| -3% | -$465K | 0.01% | 1609 |
|
|
2022
Q2 | $14.7M | Buy |
420,980
+4,567
| +1% | +$162K | 0.01% | 1611 |
|
|
2022
Q1 | $20.6M | Buy |
416,413
+53,155
| +15% | +$2.95M | 0.01% | 1524 |
|
|
2021
Q4 | $28.1M | Buy |
363,258
+8,697
| +2% | +$893K | 0.01% | 1311 |
|
|
2021
Q3 | $37.9M | Buy |
354,561
+35,685
| +11% | +$4.09M | 0.01% | 1061 |
|
|
2021
Q2 | $42.5M | Buy |
318,876
+5,274
| +2% | +$613K | 0.01% | 981 |
|
|
2021
Q1 | $38.8M | Buy |
313,602
+59,773
| +24% | +$9.08M | 0.01% | 996 |
|
|
2020
Q4 | $35.9M | Buy |
253,829
+15,842
| +7% | +$1.76M | 0.01% | 991 |
|
|
2020
Q3 | $18.1M | Buy |
237,987
+40,218
| +20% | +$2.5M | 0.01% | 1274 |
|
|
2020
Q2 | $8.96M | Buy |
197,769
+21,329
| +12% | +$765K | ﹤0.01% | 1716 |
|
|
2020
Q1 | $5.4M | Buy |
176,440
+34,908
| +25% | +$938K | ﹤0.01% | 1799 |
|
|
2019
Q4 | $2.97M | Buy |
141,532
+5,960
| +4% | +$139K | ﹤0.01% | 2282 |
|
|
2019
Q3 | $3.24M | Buy |
135,572
+6,512
| +5% | +$189K | ﹤0.01% | 2187 |
|
|
2019
Q2 | $3.75M | Buy |
129,060
+97,704
| +312% | +$2.58M | ﹤0.01% | 2112 |
|
|
2019
Q1 | $727K | Buy |
31,356
+4,437
| +16% | +$100K | ﹤0.01% | 2647 |
|
|
2018
Q4 | $622K | Buy |
+26,919
| New | +$597K | ﹤0.01% | 2690 |
|
Other funds holding TWST
AIM
EIG
Charles Schwab's TWST Position: Q2 2026 in Review
Charles Schwab increased its Twist Bioscience (TWST) stake by 3.7% in Q2 2026, buying an estimated $1.3M and bringing the position to 557,131 shares worth $57.3M. The position accounts for 0.01% of the portfolio, ranked #1157.
Charles Schwab first reported a position in TWST in Q4 2018 and has held it in 31 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.
- Charles Schwab held 557,131 shares of Twist Bioscience worth $57.3M as of Q2 2026.
- Charles Schwab bought 20,020 Twist Bioscience shares in Q2 2026, an estimated $1.3M.
- Twist Bioscience made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #1157 holding.
- Charles Schwab first reported a position in Twist Bioscience in Q4 2018 and has held it in 31 quarters since.
- 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.